Title of Invention: Matrix adjuvants and the drop pills prepared with them Abstract: The present invention relates to the matrix adjuvants for drop pills and the preparation of the drop pills. The matrix adjuvants for drop pills of the present invention comprise new matrix adjuvants with or without the plastifying components, which are typically natural matrix adjuvants derived from plants and of safety and non-toxicity. The present invention decreases the toxicity caused by polyethylene glycol, alters the situation that adjuvants derived from animals is scarce, improves the quality of drop pills and accelerates the development of drop pills. Detailed Description: FIELD OF THE INVENTION The present invention relates to pharmaceutical formulation. More specifically, the present invention relates to the matrix adjuvants for drop pills and the drop pills prepared with them. BACKGROUND OF THE INVENTION Drop pill is prepared by dripping, namely, the solid or liquid drug is dissolved, suspended or emulsified into the matrix, then the mixture is dropped into the matrix-insoluble coolant to form the pills with the shape of sphere or oblate spheroid by congealing. It can be administered orally or intracavitarily, or can be used to prepare solution, etc. Compared with other pharmaceutical formulations, the drop pill has many advantages such as easy operation of the dropping machine, small weight variation of pills, accurate content of the pharmaceutical active ingredient, low loss of drug in the processing, stability of quality, and capacity to make the drug exhibit high efficacy, enduring efficacy and quick efficacy, etc. The formulation of drop pill is especially suitable for those poorly water-soluble drugs which are difficult to be absorbed and the herbs containing volatile oil as their effective components. The development of drop pill formulation satisfies the basic requirements for the modern pharmaceutical formulation such as “three less”, i.e. less amount of administration, less toxic and less side effect; “three efficacy”, i.e. high efficacy, long efficacy and quick efficacy, and easiness to be administered, carried and stored, thus it is promising for a huge potential market. Despite the recent great development in the manufacturing machine, process and variety of medicine for drop pill, the development of research and application on the novel matrix adjuvants for drop pill is still slow. So far, polyethylene glycol (PEG) is commonly used as matrix adjuvant for most of the drop pills, and meanwhile polyoxyethylene monostearate, glutin, poloxamer, polyether and the like are selected occasionally. In terms of source, polyethylene glycol, polyoxyethylene monostearate, poloxamer and polyether and the like are produced by artificial synthesis. Glutin is derived from natural materials, but it is mainly derived from the skin and bone of animals. In terms of safety, the chemically synthesized materials such as polyethylene glycol, polyoxyethylene monostearate, poloxamer, polyether and the like are pharmaceutically acceptable, but they can cause hemolyzation to some extent. Furthermore, some chemical components such as ethylene oxide, epoxy propane and the like, which have toxic and side effects to human, are inevitably mixed into these materials during the process of chemical synthesis. In addition, these chemically synthesized materials may be incompatible with many drugs such as salicylic acid, diphenhydramine, potassium penicillin G, tetracycline, etc., which reduces the curative effect of these drugs. As for glutin, its application is limited because the original auxiliary materials derived from animals are prohibited in order to avoid the animal diseases such as mad cow disease, foot-and-mouth disease, etc. Additionally, long-term study showed that the drop pills with the polyethylene glycol were unstable because of various problems, for example, they are prone to aging and cracking, etc. So how to expand the application range of matrix for drop pill and make them suitable for the extracts of Chinese medicines with different properties (hydrophilicity or lipophilicity) to formulating to drop pills, and increase the drug loading of drop pill formulation are urgent problems need to be solved. Therefore, studying and developing some novel, safe and non-toxic matrix adjuvants of drop pill is significant for improving the product quality of drop pill, widening the application range of drop pill, driving the development of drop pill formulation and promoting the internationalization of the drop pill formulation. However, the demand of process of drop pill for the matrix adjuvants is very strict, the drop pill products which satisfy the requirements of quality are usually difficult to be prepared after the matrix adjuvant is changed. Therefore, no substitutes of polyethylene glycol which are more suitable to be used as matrix adjuvants are available now. SUMMARY OF THE INVENTION The objectives of the present invention are to change the situation that the chemically synthesized materials such as polyethylene glycol has long been used as matrix adjuvant which leads to the toxic and side effects and the scarcity of the adjuvant materials derived from animals, to reduce the amount of usage of the chemically synthesized materials and the materials derived from animals, to provide a natural, safe and non-toxic materials derived from plants used as matrix adjuvant or the main components of the matrix adjuvant for drop pills, to promote the development of the drop pills formulation, and to accelerate the internationalization of the drop pill products. Another objective of the present invention is to provide a process for preparing drop pills using or mainly using the natural matrix adjuvants derived from plants. Specifically, the present invention relates to the following: 1. A drop pill comprising the pharmaceutical active ingredient and at least one of the pharmaceutically acceptable matrix adjuvants selected from a group consisting of monosaccharide, oligosaccharide, polysaccharide, sugar ester, sugar alcohol, alpha-hydroxy acid, higher fatty acid derivative, higher aliphatic alcohol, polyol, urea, and poly(ethylene oxide) derivative. 2. The drop pill according to 1, wherein said pharmaceutical active ingredient is a extract of crude drug. 3. The drop pill according to 1, wherein said pharmaceutical active ingredient is a chemically synthesized drug, antibiotic or biochemical drug. 4. The drop pill according to any one of 1-3, wherein as the matrix adjuvants, said monosaccharide is D-ribose, fructose, glucose, xylose; said oligosaccharide is trehalose, raffinose, maltose; said polysaccharide is gelose; said sugar ester is sucrose ester, D-ribonic acid-γ-lactone; said sugar alcohol is erythritol, sorbitol, xylitol, arabitol, isomaltitol, lactitol; said alpha-hydroxy acid is malic acid, citric acid; said higher fatty acid derivative is sodium stearate, glycerin stearate, glycerin palmitate, shellac; said higher aliphatic alcohol is cetyl alcohol, stearyl alcohol; said polyol is phenyl ethanediol; said poly(ethylene oxide) derivative is polyoxyethylene monosteatate, polyoxyethylene alkyl ether, and the above-mentioned compounds containing crystal water. 5. The drop pill according to any one of 1-3, wherein said matrix adjuvant is at least one of natural adjuvants derived from plants which are selected from a group consisting of the following: sorbitol, xylitol, lactitol, maltose, sucrose ester, and the above-mentioned compounds containing crystal water. 6. The drop pill according to any one of 1-5, wherein said drop pill further comprises at least one of plastifying components selected from a group consisting of the following starch and their derivatives, cellulose and their derivatives, arabic gum, dextran, chitin, sesbania gum, carrageen gum, Indian gum, danish agar, tragacanth, carrageenin, tamarind gum, pectin, xanthan gum, alginic acid and the salts thereof, dextrin, cyclodextrin, agar, lactose; polyvinylpyrrolidone, cross-linked polyvinylpyrrolodione, carbomer, polyvinyl alcohol, acrylic acid resin, poloxamer, silicon dioxide, glutin, glycerin monostearate, polyoxyethylene monostearate. 7. The drop pill according to 6, wherein said plastifying components is one or more substances selected from a group consisting of the following: pregelatinized starch, carboxylmethyl starch, methyl cellulose, sodium carboxymethyl cellulose, hydroxypropyl methyl cellulose, arabic gum, alginic acid, dextrin, cyclodextrin, agar, lactose, glycerin monostearate, polyoxyethylene monostearate, cross-linked sodium carboxylmethyl cellulose, silicon dioxide. 8. The drop pill according to 6 or 7, wherein said matrix adjuvant includes lactitol and starch. 9. The drop pill according to 6 or 7, wherein said matrix adjuvant includes xylitol and arabic gum. 10. The drop pill according to 6 or 7, wherein said matrix adjuvant includes sucrose ester and glycerin monostearate or polyoxyethylene monostearate. 11. The drop pill according to 6 or 7, wherein said matrix adjuvant includes sucrose ester, polyoxyethylene monostearate and cross-linked sodium carboxylmethyl cellulose. 12. The drop pill according to 6 or 7, wherein said matrix adjuvant includes sucrose ester, polyoxyethylene monostearate, cross-linked sodium carboxylmethyl cellulose and silicon dioxide. 13. The drop pill according to 1, wherein the weight ratio of the matrix adjuvant to the pharmaceutical active ingredient is in the range of 1:0.1˜1:1. 14. The drop pill according to 1, wherein the weight ratio of the matrix adjuvant to the pharmaceutical active ingredient is in the range of 1:0.1˜1:0.6. 15. A matrix adjuvant for drop pill comprising xylitol and starch with the weight ratio of 1:0.2˜1:0.3. 16. A matrix adjuvant for drop pill comprising lactitol and starch with the weight ratio of 1:0.2˜1:0.3. 17. A matrix adjuvant for drop pill comprising xylitol and arabic gum with the weight ratio of 1:0.2˜1:0.4. 18. A matrix adjuvant for drop pill comprising sucrose ester and glycerin monostearate or polyoxyethylene monostearate with the weight ratio of 1:0.1˜1:1. 19. A matrix adjuvant for drop pill comprising sucrose ester polyoxyethylene monostearate and cross-linked sodium carboxylmethyl cellulose with the weight ratio of 1:(0.1˜1):(0.1˜1). 20. A matrix adjuvant for drop pill comprising sucrose ester the plastifying components including polyoxyethylene monostearate, cross-linked sodium carboxylmethyl cellulose and silicon dioxide with the weight ratio of 15:(7˜1 5):(0.1˜2):(0.1˜2). DETAILED DESCRIPTION OF THE INVENTION The drop pills of the present invention are composed of drugs and natural matrix adjuvants for drop pill which mainly derived from plants. Said drugs comprise the extract from crude drug(s), the chemically synthesized drug, antibiotic and biochemical drug. The extract from crude drug(s) of the present invention refers to the extract of all kinds of plants, animals, fungi or minerals and the like which are commonly used as traditional Chinese medicines(TCM) in China or as natural medicines in other countries, including the extract of one or more kinds of crude drugs or mixtures of the extracts. Said extracts, namely the effective fractions of medicinal materials, for example, the extracting solution, extract and liquid extract, etc., which comprise the hydrophilic and lipophilic components, and the components of volatile oil etc. are obtained by those methods commonly used in the art, for example, the crude drugs are dipped, extracted, or decocted by water or organic solvent such as methanol, ethanol, ethyl ether, petroleum ether, acetone, chloroform, etc. without or in the presence of acid or alkali. The above components may be used after further purification by the well-known methods in the art such as ion exchange resin, macroporous absorption resin, ultrafiltration membrane, silicon gel column or alumina column chromatography, high performance liquid chromatography, and the like. The mixtures of exacts above-mentioned may be obtained by extracting the aforehand mixtures of crude drugs or mixing the extracts of crude drugs, or combining the above two methods. Said extracts of crude drugs usually include, but are not limited to, all kinds of well-known natural organic compounds such as sugar, protein, nucleic acid, alkaloid, glucoside, coumarin, and lignin, volatile oil of monoterpenes and diterpenes, triterpenoids and triterpenoid saponins, cardiac glycoside and steroidal saponins, flavones, quinones, polyphenols, etc. Said extracts of the present invention generally do not include monomer drug used as the chemically cure drugs extracted from plants and animals such as morphine, paclitaxel, tetrodotoxin, reserpine, berberine, artemisinin, etc. Said extracts of crude drug of the present invention can be prepared by the well-known methods in the art or commercially available. Said chemically synthesized drugs, antibiotics or biochemical drugs of this invention refer to those which are monomer and small molecule chemically therapeutic drugs, antibiotics, protein, nucleic acids and the like with defined structure and/or unitary characteristic, and obtained in the method of chemical synthesis or extracting from leavening. The monomer drugs extracted from plants and animals are used as monomer drug itself, or further transferred to other substances which can be used as drugs. Said chemically synthesized drugs, antibiotics or biochemical drugs of this invention include, but are not limited to, sedative and hypnotic agents such as barbiturates, diazepines etc.; analgesics such as morphine, pethidine, methadone, etc; anticholinergic drugs such as atropine, anisodamine, etc.; αand β-receptor blockers; histamine H1,H2-receptor antagonists; HMG coenzyme A inhibitor; curing drugs of hepatobiliary diseases such as Schizandrin B, Schizandrin C, bifendate, silymarin, ursodeoxycholic acid, etc; antipyretic analgesics and non-steroidal anti-inflammatory drugs; anti-tumor drugs such as alkylating agents, natural and synthesized alkaloids, taxanes, anticancer antibiotics; natural and semi-synthesized and full synthesized antibiotics such as β-lactams, macrolides, aminoglycosides, chloramphenicols, etc.; synthesized antibacterial drugs such as quinolones, sulfanilamide, etc; antifungal drugs such as azoles, etc; antiviral drugs such as nucleosides or non-nucleosides; antiparasitic drugs; hormones such as prostaglandins, peptides, steroids; vitamins, immune nucleic acid, bacterin, etc. They also include, but not limit to the monomer drugs extracted from plants and animals used in the chemically cure drugs. These chemically synthesized drugs, antibiotics or biochemical drugs may be used solely or used as a complex of several above-mentioned chemically synthesized drugs, antibiotics or biochemical drugs. Said matrix adjuvants of this invention include the adjuvants mainly derived from natural materials, especially from plants. The matrix adjuvants may optionally include a plastifying component. More specifically, said matrix adjuvant of this invention is at least one of the adjuvants selected from a group consisting of the following: a pharmaceutically acceptable monosaccharide, oligosaccharide, polysaccharide, sugar ester, sugar alcohol, alpha-hydroxy acid (fruit acid), higher fatty acid derivative, higher aliphatic alcohol, polyol, urea and poly(ethylene oxide) derivative. For the above-mentioned substances, non-limiting examples of said monosaccharide include D-ribose, fructose, glucose, xylose; examples of said oligosaccharide include trehalose, raffinose, maltose; example of said polysaccharide includes gelose; examples of said sugar ester include sucrose ester, D-ribonic acid-γ-lactone; examples of said sugar alcohol include erythritol, sorbitol, xylitol, arabitol, isomaltitol, lactitol; examples of said alpha-hydroxy acid include malic acid, citric acid; examples of said higher fatty acid derivative include sodium stearate, glycerin stearate, glycerin palmitate, shellac; examples of said higher aliphatic alcohol include cetyl alcohol, stearyl alcohol; example of said polyol includes phenyl ethanediol; examples of said poly(ethylene oxide) derivative include polyoxyethylene monosteatate, polyoxyethylene alkyl ether, and the above-mentioned compounds containing crystal water. For the above-mentioned substances, said materials derived from plants include erythritol, sorbitol, fructose, D-ribonic acid-γ-lactone, arabitol, trehalose, D-ribose, low-melting point gelose, shellac, xylitol, raffinose, glucose, malic acid, citric acid, isomaltitol, lactitol, maltose, xylose, sucrose ester, etc., and the above-mentioned compounds containing crystal water; examples of said chemically synthesized adjuvants or adjuvants derived from animals include phenyl ethanediol, polyethylene glycol, cetyl alcohol, stearyl alcohol, sodium stearate, glycerin stearate, glycerin palmitate, urea, polyoxyethylene monosteatate, polyoxyethylene alkyl ether. For the above-mentioned substances, one or more adjuvants selected from sorbitol, lactitol, maltose, sucrose ester, and the above-mentioned compounds containing crystal water are most preferred. The matrix adjuvants are natural adjuvants mainly derived from plants, it means that the content of the adjuvants derived from plants is equal to or more than 50 wt % and the content of the chemically synthesized adjuvants and the adjuvants derived from animals are less than or equal to the adjuvants derived from plants in the matrix adjuvants. Preferably, only the adjuvants derived from plants is used for the matrix adjuvants of the drop pills, or the adjuvant derived from plants is the main component and only small amount of the chemically synthesized adjuvants and the adjuvants derived from animals are used. The content of the chemically synthesized adjuvants and the adjuvants derived from animals was less than 50 wt %, preferably less than 40 wt %, and more preferably less than 30 wt %. Said natural adjuvant derived from plants refers to the following: the adjuvant itself is extracted from cells or tissues of the plants, or the products obtained by modification of the extract of plants, such as derivation and the like. Said chemically synthesized adjuvants refer to the artificial synthesized small molecule compounds or polymers obtained by chemical synthesis from the simple small molecules. Said natural adjuvant derived from animals refers to the following: the adjuvant itself is extracted from cells or tissues of the animals, or the products obtained by modification of the extract of animals, such as derivation and the like. Said matrix adjuvants derived from plants may have or will have artificial synthetic products in the future. If the artificial synthetic products have identical or similar properties to the natural matrix adjuvants derived from plants, for example, they have the characteristics such as safety and non-toxicity, they may be applied as the substitutes of the natural matrix adjuvants derived from plants, just like the application of the natural matrix adjuvants derived from plants. In order to improve the shaping ability of the drop pill, preferably, the matrix further comprises plastifying components. Said plastifying components may be one or more components selected from a group consisting of the following natural adjuvants derived from plants such as starch and the derivatives thereof, cellulose and the derivatives thereof, arabic gum, dextran, chitin, sesbania gum, carrageen gum, Indian gum, danish agar, tragacanth gum, carrageenin, tamarind gum, pectin, xanthan gum, alginic acid and the salts thereof, dextrin, cyclodextrin, agar, lactose; the adjuvants chemically synthesized and derived from animals such as polyvinylpyrrolidone, cross-linked polyvinylpyrrolodione, carbomer, polyvinyl alcohol, acrylic acid resin, poloxamer, silicon dioxide, glutin, and the like. Non-limiting examples of said starch and their derivatives include pregelatinized starch, modified starch, hydroxypropyl starch, carboxylmethyl starch and the like. Non-limiting examples of said cellulose and their derivatives include methyl cellulose, microcrystalline cellulose, sodium carboxylmethyl cellulose, hydroxypropyl methyl cellulose, cross-linked sodium carboxylmethyl cellulose, hydroxyethyl methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose. Preferably, said plastifying components may be one or more components selected from a group consisting of the following: pregelatinized starch, carboxylmethyl starch, methyl cellulose, sodium carboxylmethyl cellulose, hydroxypropyl methyl cellulose, arabic gum, alginic acid, dextrin, cyclodextrin, agar, and lactose. In addition, glycerin monostearate and polyoxyethylene monostearate may also be used as plastifying components together with other matrix adjuvants. Said components derived from plants refer to the following: the adjuvant itself is extracted from cells or tissues of the plants, or obtained by modification, such as derivation and the like, of the extract of plants. Said chemically synthesized adjuvants refer to the artificial synthesized small molecule compounds or polymers obtained by chemical synthesis of simple small molecules. Said natural adjuvant derived from animals refers to the following: the adjuvant itself is extracted from cells or tissues of the animals, or obtained by modification, such as derivation and the like, of the extract of animals. Perhaps, said plastifying components derived from plants have had or will have artificial synthetic products in the future. If the artificial synthetic products have identical or similar properties to the natural plastifying components derived from plants and have the characteristics such as safe and non-toxic, they may be applied as the substitutes for the natural plastifying components derived from plants, just like the application of the natural plastifying components derived from plants. Said matrix adjuvants selected from monosaccharide, oligosaccharide, polysaccharide, sugar ester, sugar alcohol, alpha-hydroxy acid, higher fatty acid derivative, higher aliphatic alcohol, polyol, urea, poly(ethylene oxide) derivative, etc., preferably, the matrix adjuvants derived from plants are selectively combined with said plastifying components according to the characteristics of drugs. The preferred combination include, but are not limited to, the following: xylitol and starch; lactitol and starch; xylitol and arabic gum; sugar ester and glycerin monostearate; sugar ester and polyoxyethylene monostearate; sugar ester, polyoxyethylene monostearate and cross-linked sodium carboxylmethyl cellulose; sucrose ester, polyoxyethylene monostearate, cross-linked sodium carboxylmethyl cellulose and silicon dioxide. The weight ratio of said matrix adjuvant and plastifying component is 1:0˜1:1.5; preferably 1:0.1˜1:0.9; most preferably 1:0.1˜1:0.5. For said matrix adjuvant, the preferred weight ratio of xylitol and starch is 1:0.2˜1:0.3. For said matrix adjuvant, the preferred weight ratio of lactitol and starch is 1:0.2˜1:0.3. For said matrix adjuvant, the preferred weight ratio of xylitol and arabic gum is 1:0.2˜1:0.4. For said matrix adjuvant, the weight ratio of sugar ester and glycerin monostearate is 1:0.1˜1:1, most preferably 1:0.5. For said matrix adjuvant, the weight ratio of sugar ester and polyoxyethylene monostearate is 1:0.1˜1:1, most preferably 1:0.5. For said matrix adjuvant, the weight ratio of sugar ester, polyoxyethylene monostearate and cross-linked sodium carboxylmethyl cellulose is 1:(0.1˜1):(0.1˜1), most preferably 1:0.4:0.6. For said matrix adjuvant, the weight ratio of sucrose ester, polyoxyethylene monostearate, cross-linked sodium carboxylmethyl cellulose and silicon dioxide is 15:(7˜15):(0.1˜2):(0.1˜2), most preferably 15:11:1:1. The weight ratio of matrix adjuvant of the drop pills and active ingredient is 1:0.1˜1:1, more preferably 1:0.1˜1:0.6, most preferably 1:0.2˜1:0.4. One or more said matrix adjuvants are applied in the drop pills of this invention, the weight ratio of the matrix adjuvant and the active ingredient meets the requirements above-mentioned, and the weight ratio of the matrix adjuvant and the plastifying component also meets the above-mentioned requirements. The preparing process of the drop pills may use the conventional method, for example, the drop pills may be prepared according to following procedures: a. To select one or more matrix adjuvants from the above mentioned, or select at least one matrix adjuvants as well as one or more said plastifying components, and to mix them homogeneously; b. To transfer the above homogenized matrix adjuvant(s) or the matrix adjuvant mixture into a dropping machine, add active ingredients, and stir said mixture of matrix adjuvant(s) and active ingredients for homogenization; c. To heat the mixture obtained from step b to melt, drop the melted mixture into the coolant, and filter the drop pills after solidification; d. To wipe off or centrifuging the coolant on the surface of drop pills; e. To dry the wiped drop pills at a low temperature, and obtain the said drop pills. In said preparing process of the drop pills, the weight ratio of matrix adjuvant and the plastifying component is 1:0˜1.5, preferably 1:0.1˜0.9, most preferably 1:0.1˜0.5. The aim of adding plastifying component is to improve the inner cohesion and plasticity of the drop pills. Whether adding said plastifying component or not mainly depends on the property of the active ingredient. If the active ingredient itself possesses good plasticity, and has the property of inner cohesion, no plastifying component is needed, or much less plastifying component is needed. If not, a certain amount of plastifying component is needed. In said preparing process of the drop pills, the weight ratio of the matrix adjuvant and the active ingredients is 1:0.1˜1:1, more preferably 1:0.1˜1:0.6, most preferably 1:0.2˜1:0.4. In said preparing process of the drop pills, the stirring time for mixing the active ingredients with the matrix adjuvants is 10˜30 minutes; After homogenized, the heating temperature for melting or dropping the obtained mixture is 45˜95° C./more preferably 60˜95° C. Examples of coolant are liquid paraffin, methyl silicone oil or vegetable oil including bean oil, castor oil, and the like, etc., and liquid paraffin, methyl silicone oil are preferred. The temperature of the coolant is −20˜30° C., preferably 0˜18° C. The inner diameter of the dropper is 1.0˜4.0 mm, preferably 1.2˜2.5 mm. Less difference between the outer diameter and the inner diameter of the dropper is preferred. It should be noted that the invention will be better understood by reference to the above content which illustrate but do not limit the preparing process of the drop pills in any way. In addition to the advantages of the conventional drop pills, such as easy preparation, stable quality, solidifying the liquid active ingredient, convenient administration, and high and quick efficacy, the greatest advantage of the drop pills prepared in the present invention lies in the following: the matrix adjuvants used in the present invention are derived from the natural plants, or mainly comprises the matrix adjuvant derived from the natural plants. The matrix adjuvants derived from the natural plants are not only pharmaceutically acceptable, but are commonly used as additives in the food industry. Since said matrix adjuvant is not only absolutely safe without any toxic and side effects, but also very cheap and accessible, it has great value for application and popularization, thus laying a solid foundation for the internationalization of said drop pills. Hereinafter the present invention is further explained by way of examples, but the present invention should not be limited by examples in any way. Unless otherwise specified, the medicinal materials, extracts from medicinal materials and chemical drugs referred in following examples are commercially available products or prepared by the conventional method in the art, and all reagents used are commercially available. EXAMPLES Example 1 Radix Puerariae daidzein 20 g, trehalose 35 g, dextrine 20 g. Trehalose and dextrine were fully mixed and transferred to a dropping machine, to which Radix Puerariae daidzein was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 90° C. Dropping the melted mixture at temperature of 80° C. into coolant of liquid paraffin at temperature of 4° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 5.14 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 2 Extract derived from Radix Ginseng, Radix Ophiopogonis, Fructus Schisandrae in the weight ratio of 1:2:1. Said extract 15 g, arabitol 35 g, hydroxypropyl methyl cellulose 12 g, xanthan gum 6 g. Arabitol, hydroxypropyl methyl cellulose and xanthan gum, were fully mixed and transferred to a dropping machine, to which said extract was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 90° C. Dropping the melted mixture at temperature of 80° C. into coolant of liquid paraffin at temperature of 8° C. at the speed of 40 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 2.98 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 3 13 g extracts of Radix Salviae Miftiorrhizae, 5 g extracts of Radix Notoginseng (WO 02/058625 A2), borneol 1.2 g, lactitol 45 g, pregelatinized starch 12 g. Lactitol and pregelatinized starch were fully mixed and transferred to a dropping machine, to which the extracts of Radix Salviae Miltiorrhizae, the extracts of Radix Notoginseng and borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 83° C. Dropping the melted mixture at temperature of 70° C. into coolant of methyl silicone oil at temperature of 0° C. at the speed of 35 pellets/min. After shaping, the methyl silicone oil on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.96 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 4 Radix Paeoniae Alba, Herba Ephedrae and Radix Glycyrrhizae were extracted with water; Rhizoma Pinelliae Preparata, Rhizoma Zingiberis, and Fructus Schisandrae Chinensis were extracted with ethanol. The above two extracting solutions were combined and concentrated to be extracts; the volatile oil was obtained by distilling of Herba Asari, Ramulus Cinnamomi, respectively. Said extracts 16 g, arabitol 20 g, carboxylmethyl starch 169. Arabitol and carboxylmethyl starch were fully mixed and transferred to a dropping machine, to which the extracts and volatile oil were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 80° C. Dropping the melted mixture at temperature of 70° C. into coolant of liquid paraffin at temperature of 4° C. at the speed of 40 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.10 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 5 Rhizoma Coptidis, Cortex Phellodendri, Fructus Gardeniae, and Radix Scutellariae with the weight ratio of 1.6:1.1:1.1:2.2 were extracted with water, precipitating with alcohol, then concentrated to obtain the extract. Said extract 12 g, xylitol 30 g, methyl cellulose 18 g, starch 5 g. Xylitol methyl cellulose and starch were fully mixed and transferred to a dropping machine, to which the extract was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 90° C. Dropping the melted mixture at temperature of 85° C. into coolant of liquid paraffin at temperature of 10° C. at the speed of 30 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.76 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 6 Extract of leech (Whitmania pigra Whitman) 20 g, sorbitol 40 g, methyl cellulose 15 g. Sorbitol and methyl cellulose were fully mixed and transferred to a dropping machine, to which the extract of leech was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 85° C. Dropping the melted mixture at temperature of 80° C. into coolant of liquid paraffin at temperature of 8° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 4.10 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 7 Radix Bupleuri was extracted with hot water, precipitating with alcohol, then concentrated to obtain the extract. Said extract 18 g, xylitol 35 g, starch 12 g. Xylitol and starch were fully mixed and transferred to a dropping machine, to which the extract was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 85° C. Dropping the melted mixture at temperature of 75° C. into coolant of methyl silicone oil at temperature of 4° C. at the speed of 35 pellets/min. After shaping, the methyl silicone oil on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.25 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 8 The volatile oil of Radix Bupleuri was obtained by method of supercritical extraction, the residue was extracted to obtain saikosaponin as the effective component, and then the extract was obtained. Said extract 20 g, maltose 40 g, carboxylmethyl cellulose 10 g. Maltose and carboxylmethyl cellulose were fully mixed and transferred to a dropping machine, to which the extract and the volatile oil were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 85° C. Dropping the melted mixture at temperature of 70° C. into coolant of liquid paraffin at temperature of 5° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 4.15 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 9 Oil of Blumea balsamifera (L.) DC. 14 g, borneol 19, lactitol 35 g, arabic gum 20 g. Lactitol and arabic gum were fully mixed and transferred to a dropping machine, to which oil of Blumea balsamifera (L.) DC. and borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 70° C. Dropping the melted mixture at temperature of 60° C. into coolant of liquid paraffin at temperature of 0° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.43 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 10 Extract of Radix Salviae Miltiorrhizae and Radix Notoginseng (Chinese Patent No. CN 1348815 A) 12 g, borneol 1.2 g, xylitol 40 g, starch 8 g. Xylitol and starch were fully mixed and transferred to a dropping machine, to which extracts of Radix Salviae Miltiorrhizae and Radix Notoginseng and borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 80° C. Dropping the melted mixture at temperature of 64° C. into coolant of methyl silicone oil at temperature of 0° C. at the speed of 40 pellets/min. After shaping, the methyl silicone oil on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.63 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 11 Extract of Radix Puerariae (the content of pueraria flavones is more than 80%) 15 g, lactitol 25 g, carrageen gum 20 g, starch 6 g. Lactitol, carrageen gum and starch were fully mixed and transferred to a dropping machine, to which extract of Radix Puerariae was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 90° C. Dropping the melted mixture at temperature of 85° C. into coolant of methyl silicone oil at temperature of 10° C. at the speed of 40 pellets/min. After shaping, the methyl silicone oil on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.64 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 12 Extract of Radix Puerariae (the content of pueraria flavones is more than 40%, and the content of puerarin is more than 28%) 15 g, fructose 25 g, carrageen gum 20 g, starch 6 g. Fructose, carrageen gum and starch were fully mixed and transferred to a dropping machine, to which extract of Radix Puerariae was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 90° C. Dropping the melted mixture at temperature of 85° C. into coolant of liquid paraffin at temperature of 10° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.15 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 13 Oleum Rhododendri Daurici 13 g, isomaltitol 20 g, alginic acid 15 g. Isomaltitol and alginic acid were fully mixed and transferred to a dropping machine, to which Oleum Rhododendri Daurici was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 80° C. Dropping the melted mixture at temperature of 70° C. into coolant of liquid paraffin at temperature of 4° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.78 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 14 Oleum Viticis Negundo 12 g, isomaltitol 35 g, carrageen gum 12 g. Isomaltitol and carrageen gum were fully mixed and transferred to a dropping machine, to which Oleum Viticis Negundo was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 80° C. Dropping the melted mixture at temperature of 65° C. into coolant of liquid paraffin at temperature of 0° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.55 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 15 Extract of Radix Salviae Miltiorrhizae and Radix Notoginseng (Chinese Patent No. CN 1348815 A) 22 g, borneol 1.5 g, lactitol 40 g, arabic gum 15 g. Lactitol and arabic gum in the formulation were fully mixed and transferred to a dropping machine, to which extracts of Radix Salviae Miltiorrhizae and Radix Notoginseng and borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 85° C. Dropping the melted mixture at temperature of 64° C. into coolant of liquid paraffin at temperature of 4° C. at the speed of 40 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 4.25 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 16 Extracts derived from Flos Lonicerae, Radix Scutellariae, Fructus Forsythiae with the weight ratio of 1:1:2. Said extracts 20 g, arabitol 35 g, cyclodextrin 15 g. Aarabitol and cyclodextrin were fully mixed and transferred to a dropping machine, to which the extract was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 95° C. Dropping the melted mixture at temperature of 80° C. into coolant of liquid paraffin at temperature of 10° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.68 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 17 Styrallyl ester 12 g, borneol 0.5 g, xylitol 40 g, hydroxypropyl methyl cellulose 10 g. Xylitol and hydroxypropyl methyl cellulose were fully mixed and transferred to a dropping machine, to which styrallyl ester and borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 75° C. Dropping the melted mixture at temperature of 60° C. into coolant of liquid paraffin at temperature of 0° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.10 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 18 The volatile oil of Rhizoma Chuanxiong was obtained by method of supercritical extraction, the residue was extracted with the low concentration ethanol, and concentrated to obtain the extract. Said extract 12 g, borneol 0.5 g, lactitol 35 g, alginic acid 15 g. Lactitol and alginic acid were fully mixed and transferred to a dropping machine, to which the extract, volatile oil and borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 85° C. Dropping the melted mixture at temperature of 65° C. into coolant of liquid paraffin at temperature of 0° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.22 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 19 The extract of Erigeron brevsicapus (Vant) Hand-Mazz, Folium Ginkgo, Radix Salviae Miltorrhizae and natural borneol was prepared according to the method of yinzhanxinmai drop pilldrop pills in National Specification Compilation of Traditional Chinese Patent Medicines Preparations, Part of Internal medicine and Heart. Said extract 15 g, arabitol 40 g, dextrin 12 g, xanthan gum 5 g. Arabitol, dextrin and xanthan gum were fully mixed and transferred to a dropping machine, to which the extract and borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 90° C. Dropping the melted mixture at temperature of 75° C. into coolant of methyl silicone oil at temperature of 8° C. at the speed of 35 pellets/min. After shaping, the methyl silicone oil on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 4.16 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 20 The ethyl ether extract of Rhizoma Chuanxiong: 7.5 g; the ethyl ether extract of Radix Angelicae Sinensis: 13.5 g; D-ribonic acid-γ-lactone 30 g; carrageen gum 12 g. D-ribonic acid-γ-lactone and carrageen gum were fully mixed and transferred to a dropping machine, to which the ethyl ether extract of Rhizoma Chuanxiong and Radix Angelicae Sinensis were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 85° C. Dropping the melted mixture at temperature of 75° C. into coolant of liquid paraffin at temperature of 4° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.35 min without baffle, which complied with the requirements of the Chinese. Example 21 Sonqi tofal Saponins std. 12 g, xylitol 35 g, lactose 12 g, arabic gum 5 g. Xylitol, lactose and arabic gum were fully mixed and transferred to a dropping machine, to which Sonqi tofal Saponins std. was added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 85° C. Dropping the melted mixture at temperature of 75° C. into coolant of liquid paraffin at temperature of 10° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pilldrop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 4.65 min without baffle, which complied with the requirements of the Chinese Pharmacopoeia. Example 22 Essential oil of Cinnamomum migao H. W. Li extracted by the water vapor distillation: 5 g; extract of Bulbus Alli Macrostemi with ethanol: 4 g; natural borneol 2 g; sorbitol 30 g; alginic acid 15 g. Sorbitol and alginic acid were fully mixed and transferred to a dropping machine, to which essential oil of Cinnamomum migao H. W. Li, extract of Bulbus Alli Macrostemi and natural borneol were added. The mixture was stirred to homogenize, then heated to be molten using a water-bath at temperature of 80° C. Dropping the melted mixture at temperature of 75° C. into coolant of liquid paraffin at temperature of 0° C. at the speed of 35 pellets/min. After shaping, the liquid paraffin on the surface of the drop pills was absorbed using absorbing paper, and then the drop pills were obtained by drying at a low temperature. The results indicated that the produced drop pills were sphere with even size, uniform color and without conglutination. Determination results of disintegration time according to the method described in Chinese Pharmacopoeia (2000) revealed that the drop pills passed the wire mesh completely within the mean time of 3.78 min without baffle, which complied with the requirements of
{'application_number': '<application-reference appl-type="utility">\n<document-id>\n<country>US</country>\n<doc-number>10563078</doc-number>\n<date>20040207</date>\n</document-id>\n</application-reference>', 'publication_number': '<publication-reference>\n<document-id>\n<country>US</country>\n<doc-number>20070059358</doc-number>\n<kind>A1</kind>\n<date>20070315</date>\n</document-id>\n</publication-reference>', 'source_file': './application/2007/ipa070315.xml', 'source_data': 'USPTO-Application'}